Rapid progression seen between first and second recurrence in isocitrate dehydrogenase mutant gliomas

Isocitrate dehydrogenase (IDH) mutant gliomas show accelerated progression from an indolent course to a fulminant malignant phase after first recurrence, specialists have found.